Patients with hereditary angioedema lack C-1 inhibitor, a plasma alpha 2-glycoprotein that inhibits both the proteolytic action of C1, the activated first component of the complement system, and the activity of components of the contact phase of coagulation: kallikrein, factor XIa, and factor XIIa. Such patients have been shown to have low levels of C4 and C2, the natural substrates for C-1, but the levels were not correlated with the presence of symptoms. We studied three patients with angioedema for evidence of activation of the contact system and found that during a symptomatic period they had decreased levels of prekallikrein, a substrate for the activated forms of factor XII, and reductions in high-molecular-weight kininogen, a substrate for plasma kallikrein. These observations suggest that zymogens of the contact system are activated during attacks of hereditary angioedema and that some of the clinical manifestations may be mediated through products of this pathway, such as kinins.
This article has been cited by other articles:
Merkulov, S., Zhang, W.-M., Komar, A. A., Schmaier, A. H., Barnes, E., Zhou, Y., Lu, X., Iwaki, T., Castellino, F. J., Luo, G., McCrae, K. R.
(2008). Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood
111: 1274-1281
[Abstract][Full Text]
Renne, T., Schuh, K., Muller-Esterl, W.
(2005). Local Bradykinin Formation Is Controlled by Glycosaminoglycans. J. Immunol.
175: 3377-3385
[Abstract][Full Text]
Espinola, R. G., Uknis, A., Sainz, I. M., Isordia-Salas, I., Pixley, R., DeLa Cadena, R., Long, W., Agelan, A., Gaughan, J., Adam, A., Colman, R. W.
(2004). A Monoclonal Antibody to High-Molecular Weight Kininogen Is Therapeutic in a Rodent Model of Reactive Arthritis. Am. J. Pathol.
165: 969-976
[Abstract][Full Text]
Lefebvre, J., Murphey, L. J., Hartert, T. V., Jiao Shan, R., Simmons, W. H., Brown, N. J.
(2002). Dipeptidyl Peptidase IV Activity in Patients With ACE-Inhibitor-Associated Angioedema. Hypertension
39: 460-464
[Abstract][Full Text]
Jiang, H., Wagner, E., Zhang, H., Frank, M. M.
(2001). Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway. J. Exp. Med.
194: 1609-1616
[Abstract][Full Text]
Nzeako, U. C., Frigas, E., Tremaine, W. J.
(2001). Hereditary Angioedema: A Broad Review for Clinicians. Arch Intern Med
161: 2417-2429
[Abstract][Full Text]
De Backer, A. I., De Schepper, A. M., Vandevenne, J. E., Schoeters, P., Michielsen, P., Stevens, W. J.
(2001). CT of Angioedema of the Small Bowel. Am. J. Roentgenol.
176: 649-652
[Abstract][Full Text]
Colman, R. W., Schmaier, A. H.
(1997). Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes. Blood
90: 3819-3843
[Full Text]
Cugno, M., Cicardi, M., Bottasso, B., Coppola, R., Paonessa, R., Mannucci, P. M., Agostoni, A.
(1997). Activation of the Coagulation Cascade in C1-Inhibitor Deficiencies. Blood
89: 3213-3218
[Abstract][Full Text]
Cicardi, M., Agostoni, A.
(1996). Hereditary Angioedema. NEJM
334: 1666-1667
[Full Text]
Previous
